personal growth paper
fadoo
UppersDownersAllArounders-8thEdition-CH10.pptx10.1 - Various reports from the Journal of the American Medical Association found:
50% of the people with severe mental health disorders are affected by substance abuse.
37% of alcohol abusers have at least one mental illness.
53% of drug abusers have at least one severe form of mental illness.
47 % of those with schizophrenia had a substance use disorder.
61 % of those with bi-polar disorder had a substance use disorder.
The incidence of dual diagnosis can vary greatly depending on the population studied, diagnostic procedures and a number of other factors.
1
10.2 – Affective and mood disorders like addiction have a genetic component to its development.
2
10.3 – The development of effective medications to better manage psychiatric disorders has greatly decreased hospitalization needs for this problem. More medications are in development to treat mental health disorders than any other medical condition. Medications in development to treat addictions are almost as abundant.
3
10.4 – Though treatment of both mental health and addictive disorders were merged into a single Behavioral Health process, de facto segregation of treatment for each continues. This is partially due to the conflicts resulting from these 12 differences in treatment philosophies.
4
10.5 – As understanding and acceptance of addiction being a mental disorder increases more and more medications are being used in its treatment and confrontational interventions are being discouraged.
5
10.6 – Confidentiality regulations and HIPPA requirements make the sharing of patient information between mental health and addiction treatment facilities difficult.
6
10.7 – The evolving science of substance-related and addictive disorders is eroding the differences between mental health and addiction treatment philosophies.
7
10.8 – Programs that are privileged to have both addiction and mental health professionals on staff can utilize the Minkoff Four-Quadrant Model to determine the most appropriate and effective clinical interventions for clients with co-occurring disorders.
8
10.9 – The annual prevalence of substance-related and addictive disorders in America is 10-12% of adults excluding tobacco or nicotine disorder.
9
10.10 – Mental health disorders result from imbalances of the brains neurotransmitters caused by addiction. The symptoms of substance abuse can be mistaken for mental illness and addiction can mask or manifest symptoms of mental illness.
10
10.11 – Cocaine/methamphetamine use can look like mania and even paranoid psychosis. Withdrawal from those drugs looks like major depression. Binging on either drug mimics bipolar disorder.
11
10.12 – Heroin like cortisone effectively suppresses the stress reaction but can lead to stress hypersensitivity. Chronic marijuana use can result in memory problems and thought disorder.
12
10.13 – Depression results from imbalance if serotonin functioning in the brain. There are many different types, sub-types and classes of serotonin receptors in the brain. Thus, only about 40% of people who are treated for depression react favorably to the first antidepressant prescribed. In the future, genetic testing may better match medication to the person being treated. This is knows as pharmcogenomics.
13
10.14 – Most psychiatric medications do not cause obsession or compulsive use. Though many can cause physical dependence they can be used in addicts without activating their brain’s addiction pathway.
14
10.15 – Benzodiazepine and sedatives used to treat anxiety disorder do activate the addiction pathway and should be used with great caution in patients with dual diagnosis.
15
10.16 – Stimulants used to treat attention-deficit/hyperactivity disorders also activate the addiction pathway and recent research on their use in adolescence has been linked to future addiction. When stimulants are used in dual diagnosis adults, they can cause relapse.
16
